Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drinking | 5 | 2014 | 35 | 1.630 |
Why?
|
| Angiotensin II | 5 | 2014 | 220 | 1.610 |
Why?
|
| Drinking Behavior | 2 | 2013 | 20 | 0.860 |
Why?
|
| Ventral Tegmental Area | 3 | 2019 | 74 | 0.720 |
Why?
|
| Punishment | 2 | 2019 | 25 | 0.720 |
Why?
|
| Habenula | 1 | 2020 | 13 | 0.700 |
Why?
|
| Basal Forebrain | 1 | 2020 | 15 | 0.700 |
Why?
|
| Reward | 2 | 2019 | 201 | 0.640 |
Why?
|
| Conditioning, Operant | 1 | 2016 | 241 | 0.490 |
Why?
|
| Third Ventricle | 1 | 2013 | 4 | 0.460 |
Why?
|
| Receptor, Angiotensin, Type 1 | 2 | 2012 | 80 | 0.450 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2019 | 2083 | 0.420 |
Why?
|
| Enzyme Activators | 1 | 2012 | 14 | 0.420 |
Why?
|
| Drug Tolerance | 1 | 2011 | 80 | 0.400 |
Why?
|
| Vasoconstriction | 1 | 2011 | 81 | 0.390 |
Why?
|
| Avoidance Learning | 1 | 2011 | 58 | 0.380 |
Why?
|
| Choice Behavior | 1 | 2011 | 85 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 250 | 0.380 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 247 | 0.370 |
Why?
|
| Rats | 7 | 2019 | 5300 | 0.370 |
Why?
|
| Behavior, Animal | 2 | 2018 | 470 | 0.370 |
Why?
|
| Fenbendazole | 1 | 2008 | 1 | 0.330 |
Why?
|
| Antinematodal Agents | 1 | 2008 | 4 | 0.330 |
Why?
|
| Animals, Laboratory | 1 | 2008 | 21 | 0.320 |
Why?
|
| Injections, Intraventricular | 3 | 2013 | 50 | 0.320 |
Why?
|
| Eating | 1 | 2008 | 119 | 0.310 |
Why?
|
| Diet | 1 | 2008 | 514 | 0.250 |
Why?
|
| Neurons | 2 | 2020 | 881 | 0.220 |
Why?
|
| Animals | 9 | 2019 | 20881 | 0.220 |
Why?
|
| Brain | 1 | 2012 | 2176 | 0.190 |
Why?
|
| Neural Pathways | 2 | 2019 | 324 | 0.180 |
Why?
|
| Tegmentum Mesencephali | 1 | 2019 | 52 | 0.170 |
Why?
|
| Male | 9 | 2019 | 37321 | 0.160 |
Why?
|
| Protein Precursors | 1 | 2018 | 105 | 0.160 |
Why?
|
| Receptors, Opioid | 1 | 2018 | 60 | 0.160 |
Why?
|
| Forkhead Transcription Factors | 1 | 2018 | 94 | 0.160 |
Why?
|
| Learning | 1 | 2019 | 186 | 0.150 |
Why?
|
| Repressor Proteins | 1 | 2018 | 183 | 0.150 |
Why?
|
| Rats, Transgenic | 1 | 2016 | 24 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2020 | 332 | 0.140 |
Why?
|
| Motivation | 1 | 2020 | 561 | 0.130 |
Why?
|
| Preoptic Area | 1 | 2014 | 19 | 0.120 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2014 | 15 | 0.120 |
Why?
|
| Central Nervous System Agents | 1 | 2014 | 37 | 0.120 |
Why?
|
| Butadienes | 1 | 2012 | 26 | 0.100 |
Why?
|
| Nitriles | 1 | 2012 | 68 | 0.100 |
Why?
|
| Carbachol | 1 | 2011 | 34 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 2012 | 136 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2011 | 289 | 0.090 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 567 | 0.090 |
Why?
|
| Enzyme Activation | 1 | 2012 | 791 | 0.090 |
Why?
|
| Losartan | 1 | 2010 | 45 | 0.090 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2010 | 21 | 0.090 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2012 | 331 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2012 | 1200 | 0.080 |
Why?
|
| Food Preferences | 1 | 2008 | 46 | 0.080 |
Why?
|
| Time Factors | 2 | 2018 | 4655 | 0.080 |
Why?
|
| Neurons, Afferent | 1 | 2019 | 32 | 0.040 |
Why?
|
| Optogenetics | 1 | 2018 | 20 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2018 | 114 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 1033 | 0.030 |
Why?
|
| Motor Activity | 1 | 2018 | 621 | 0.030 |
Why?
|
| Subfornical Organ | 1 | 2014 | 1 | 0.030 |
Why?
|
| Angiotensin II Type 2 Receptor Blockers | 1 | 2014 | 2 | 0.030 |
Why?
|
| 1-Sarcosine-8-Isoleucine Angiotensin II | 1 | 2014 | 5 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2014 | 109 | 0.030 |
Why?
|
| Receptor, Angiotensin, Type 2 | 1 | 2014 | 31 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 2014 | 119 | 0.030 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2014 | 50 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2014 | 95 | 0.030 |
Why?
|
| Drinking Water | 1 | 2014 | 33 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 114 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1293 | 0.030 |
Why?
|